Related by context. Frequent words. (Click for all words.) 69 NKTR 65 AEZS 65 AP# [003] 65 MGCD# [001] 64 MGCD# [002] 64 ARRY 63 HspE7 62 ITMN 61 ENMD 61 Phase Ib 61 preclinical studies 60 XL# [003] 60 IMGN# 59 RNAi therapeutic 59 preclinical 59 perifosine 59 MDV# 59 Phase 2a 59 RDEA# 58 INCB# [002] 58 CYT# 58 PLX# 58 small molecule inhibitor 58 PRX # 58 hematological malignancies 58 anticancer agents 58 Phase 2a clinical 58 Phase 1b 58 INNO 58 ARQ 57 XOMA 57 iCo 57 elesclomol 57 bavituximab 57 humanized monoclonal antibody 57 Phase 2b trial 56 LymphoStat B 56 LEVADEX 56 AZD# 56 IDX# 56 tivozanib 56 solid tumors 56 T DM1 55 AEOL # 55 Phase IIa clinical 55 investigational compound 55 Phase IIa trial 55 Phase 2b clinical 55 picoplatin 55 carfilzomib 55 Phase IIb trial 54 kinase inhibitors 54 REOLYSIN R 54 Preclinical 54 Phase 2b study 54 Phase III clinical 54 Preclinical studies 54 bortezomib 54 antiviral activity 54 anti angiogenic 54 Phase IIb 54 Phase IIb clinical 54 hematologic malignancies 54 ADVEXIN 54 MB# [004] 54 antitumor activity 54 Phase 2b 53 ASA# 53 pivotal Phase III 53 ALKS 53 ispinesib 53 small molecule 53 metastatic melanoma 53 daclizumab 53 NovaBay 53 oncology indications 53 Marqibo 53 REOLYSIN 53 Opexa 53 ANX 52 investigational drug 52 APD# 52 mipomersen 52 CK # 52 Locteron 52 prodrug 52 dose escalation 52 antisense 52 Corcept 52 dose escalation study 52 ANA# 52 Phase IIa 52 Tovaxin 52 Phase II 52 therapeutic antibody 51 FTY# 51 human monoclonal antibody 51 Phase III 51 taxane 51 InNexus 51 immunotherapeutic